A detailed history of Nomura Holdings Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Nomura Holdings Inc holds 11,385 shares of REGN stock, worth $7.74 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
11,385
Previous 11,385 -0.0%
Holding current value
$7.74 Million
Previous $12 Million -0.0%
% of portfolio
0.03%
Previous 0.03%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1024.09 - $1201.76 $8.42 Million - $9.88 Million
8,218 Added 259.49%
11,385 $12 Million
Q2 2024

Aug 14, 2024

BUY
$883.2 - $1071.19 $2 Million - $2.43 Million
2,264 Added 250.72%
3,167 $3.33 Million
Q1 2024

May 15, 2024

BUY
$902.69 - $993.35 $815,129 - $896,995
903 New
903 $869,000
Q4 2023

Feb 14, 2024

BUY
$775.18 - $881.7 $3.83 Million - $4.35 Million
4,937 New
4,937 $4.34 Million
Q2 2023

Aug 14, 2023

BUY
$700.03 - $830.35 $766,532 - $909,233
1,095 Added 190.77%
1,669 $1.2 Million
Q1 2023

May 15, 2023

BUY
$680.49 - $826.97 $390,601 - $474,680
574 New
574 $471,000
Q2 2022

Aug 15, 2022

SELL
$548.35 - $738.84 $703,533 - $947,931
-1,283 Reduced 68.72%
584 $347,000
Q1 2022

May 18, 2022

BUY
$595.12 - $698.43 $8,926 - $10,476
15 Added 0.81%
1,867 $1.3 Million
Q4 2021

Feb 14, 2022

SELL
$543.48 - $670.97 $308,696 - $381,110
-568 Reduced 23.47%
1,852 $1.17 Million
Q3 2021

Nov 15, 2021

SELL
$574.03 - $680.96 $4,592 - $5,447
-8 Reduced 0.33%
2,420 $1.38 Million
Q2 2021

Aug 16, 2021

SELL
$472.8 - $558.54 $8.02 Million - $9.48 Million
-16,972 Reduced 87.48%
2,428 $1.36 Million
Q1 2021

May 17, 2021

BUY
$446.73 - $548.2 $5.55 Million - $6.81 Million
12,425 Added 178.14%
19,400 $9.18 Million
Q4 2020

Feb 16, 2021

BUY
$478.3 - $607.98 $2 Million - $2.55 Million
4,189 Added 150.36%
6,975 $3.36 Million
Q3 2020

Nov 12, 2020

SELL
$544.75 - $658.21 $738,136 - $891,874
-1,355 Reduced 32.72%
2,786 $1.56 Million
Q2 2020

Aug 14, 2020

BUY
$493.32 - $643.92 $2.04 Million - $2.67 Million
4,141 New
4,141 $2.58 Million
Q1 2020

May 14, 2020

SELL
$336.18 - $494.43 $358,367 - $527,062
-1,066 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$274.13 - $376.51 $292,222 - $401,359
1,066 New
1,066 $400,000
Q3 2018

Nov 14, 2018

SELL
$351.14 - $408.51 $532,328 - $619,301
-1,516 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$284.6 - $344.99 $1.29 Million - $1.56 Million
-4,520 Reduced 74.88%
1,516 $407,000
Q1 2018

May 14, 2018

SELL
$315.82 - $393.78 $2.52 Million - $3.14 Million
-7,977 Reduced 56.93%
6,036 $2.08 Million
Q1 2018

May 14, 2018

BUY
$315.82 - $393.78 $1.91 Million - $2.38 Million
6,036 Added 75.67%
14,013 $5.08 Million
Q4 2017

Feb 14, 2018

BUY
$358.63 - $469.95 $375,844 - $492,507
1,048 Added 15.12%
7,977 $3 Million
Q3 2017

Nov 14, 2017

BUY
$431.38 - $504.0 $2.99 Million - $3.49 Million
6,929
6,929 $3.1 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $72.9B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Nomura Holdings Inc Portfolio

Follow Nomura Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.